Literature DB >> 21490317

Leaky sodium channels from voltage sensor mutations in periodic paralysis, but not paramyotonia.

David G Francis1, Volodymyr Rybalchenko, Arie Struyk, Stephen C Cannon.   

Abstract

BACKGROUND: Hypokalemic periodic paralysis (HypoPP) is associated with mutations in either the Ca(V)1.1 calcium channel or the Na(V)1.4 sodium channel. Some Na(V)1.4 HypoPP mutations have been shown to cause an anomalous inward current that may contribute to the attacks of paralysis. Herein, we test whether disease-associated Na(V)1.4 mutations in previously untested homologous regions of the channel also give rise to the anomalous current.
METHODS: The functional properties of mutant Na(V)1.4 channels were studied with voltage-clamp techniques in an oocyte expression system.
RESULTS: The HypoPP mutation Na(V)1.4-R1132Q conducts an anomalous gating pore current, but the homologous R1448C mutation in paramyotonia congenita does not.
CONCLUSIONS: Gating pore currents arising from missense mutations at arginine residues in the voltage sensor domains of Na(V)1.4 are a common feature of HypoPP mutant channels and contribute to the attacks of paralysis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21490317      PMCID: PMC3100087          DOI: 10.1212/WNL.0b013e318219fb57

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

1.  The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation.

Authors:  A F Struyk; K A Scoggan; D E Bulman; S C Cannon
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

2.  Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A.

Authors:  D Sternberg; T Maisonobe; K Jurkat-Rott; S Nicole; E Launay; D Chauveau; N Tabti; F Lehmann-Horn; B Hainque; B Fontaine
Journal:  Brain       Date:  2001-06       Impact factor: 13.501

3.  Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.

Authors:  E R Liman; J Tytgat; P Hess
Journal:  Neuron       Date:  1992-11       Impact factor: 17.173

4.  A novel sodium channel mutation in a family with hypokalemic periodic paralysis.

Authors:  D E Bulman; K A Scoggan; M D van Oene; M W Nicolle; A F Hahn; L L Tollar; G C Ebers
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

Review 5.  Voltage-sensor mutations in channelopathies of skeletal muscle.

Authors:  Stephen C Cannon
Journal:  J Physiol       Date:  2010-02-15       Impact factor: 5.182

6.  Charges and potentials at the nerve surface. Divalent ions and pH.

Authors:  B Hille
Journal:  J Gen Physiol       Date:  1968-02       Impact factor: 4.086

7.  Acetazolamide prophylaxis in hypokalemic periodic paralysis.

Authors:  J S Resnick; W K Engel; R C Griggs; A C Stam
Journal:  N Engl J Med       Date:  1968-03-14       Impact factor: 91.245

8.  Hypokalemic periodic paralysis studies in vitro.

Authors:  W W Hofmann; R A Smith
Journal:  Brain       Date:  1970       Impact factor: 13.501

9.  Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current.

Authors:  K Jurkat-Rott; N Mitrovic; C Hang; A Kouzmekine; P Iaizzo; J Herzog; H Lerche; S Nicole; J Vale-Santos; D Chauveau; B Fontaine; F Lehmann-Horn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

10.  Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis.

Authors:  E Matthews; R Labrum; M G Sweeney; R Sud; A Haworth; P F Chinnery; G Meola; S Schorge; D M Kullmann; M B Davis; M G Hanna
Journal:  Neurology       Date:  2008-12-31       Impact factor: 9.910

View more
  28 in total

1.  A sodium channel knockin mutant (NaV1.4-R669H) mouse model of hypokalemic periodic paralysis.

Authors:  Fenfen Wu; Wentao Mi; Dennis K Burns; Yu Fu; Hillery F Gray; Arie F Struyk; Stephen C Cannon
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

2.  Gating pore currents and the resting state of Nav1.4 voltage sensor domains.

Authors:  Pascal Gosselin-Badaroudine; Lucie Delemotte; Adrien Moreau; Michael L Klein; Mohamed Chahine
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-07       Impact factor: 11.205

Review 3.  The divergence, actions, roles, and relatives of sodium-coupled bicarbonate transporters.

Authors:  Mark D Parker; Walter F Boron
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 4.  Sodium Channelopathies of Skeletal Muscle.

Authors:  Stephen C Cannon
Journal:  Handb Exp Pharmacol       Date:  2018

Review 5.  Channelopathies of skeletal muscle excitability.

Authors:  Stephen C Cannon
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

6.  HCO(3)(-)-independent conductance with a mutant Na(+)/HCO(3)(-) cotransporter (SLC4A4) in a case of proximal renal tubular acidosis with hypokalaemic paralysis.

Authors:  Mark D Parker; Xue Qin; Rosalind C Williamson; Ashley M Toye; Walter F Boron
Journal:  J Physiol       Date:  2012-02-13       Impact factor: 5.182

7.  A calcium channel mutant mouse model of hypokalemic periodic paralysis.

Authors:  Fenfen Wu; Wentao Mi; Erick O Hernández-Ochoa; Dennis K Burns; Yu Fu; Hillery F Gray; Arie F Struyk; Martin F Schneider; Stephen C Cannon
Journal:  J Clin Invest       Date:  2012-11-26       Impact factor: 14.808

8.  Mice with an NaV1.4 sodium channel null allele have latent myasthenia, without susceptibility to periodic paralysis.

Authors:  Fenfen Wu; Wentao Mi; Yu Fu; Arie Struyk; Stephen C Cannon
Journal:  Brain       Date:  2016-04-05       Impact factor: 13.501

Review 9.  Novel insights into the pathomechanisms of skeletal muscle channelopathies.

Authors:  James A Burge; Michael G Hanna
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

10.  A recessive Nav1.4 mutation underlies congenital myasthenic syndrome with periodic paralysis.

Authors:  Karima Habbout; Hugo Poulin; François Rivier; Serena Giuliano; Damien Sternberg; Bertrand Fontaine; Bruno Eymard; Raul Juntas Morales; Bernard Echenne; Louise King; Michael G Hanna; Roope Männikkö; Mohamed Chahine; Sophie Nicole; Said Bendahhou
Journal:  Neurology       Date:  2015-12-11       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.